Pulmonary Hypertension : (Record no. 60840)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 05385nam a22004573i 4500 |
001 - CONTROL NUMBER | |
control field | EBC3020361 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | MiAaPQ |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20240729124136.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
fixed length control field | m o d | |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr cnu|||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 240724s2012 xx o ||||0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9781614706663 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
Canceled/invalid ISBN | 9781614705567 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (MiAaPQ)EBC3020361 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (Au-PeEL)EBL3020361 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (CaPaEBR)ebr10676650 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (OCoLC)829713274 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | MiAaPQ |
Language of cataloging | eng |
Description conventions | rda |
-- | pn |
Transcribing agency | MiAaPQ |
Modifying agency | MiAaPQ |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RC776.P87 -- P85652 2012eb |
082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 616.2/4 |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Gan, Huili. |
245 10 - TITLE STATEMENT | |
Title | Pulmonary Hypertension : |
Remainder of title | Pathogenesis, Diagnosis and Treatments. |
250 ## - EDITION STATEMENT | |
Edition statement | 1st ed. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Place of production, publication, distribution, manufacture | Hauppauge : |
Name of producer, publisher, distributor, manufacturer | Nova Science Publishers, Incorporated, |
Date of production, publication, distribution, manufacture, or copyright notice | 2012. |
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | ©2012. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 online resource (172 pages) |
336 ## - CONTENT TYPE | |
Content type term | text |
Content type code | txt |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media type term | computer |
Media type code | c |
Source | rdamedia |
338 ## - CARRIER TYPE | |
Carrier type term | online resource |
Carrier type code | cr |
Source | rdacarrier |
490 1# - SERIES STATEMENT | |
Series statement | Cardiology Research and Clinical Developments |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Intro -- PULMONARY HYPERTENSIONPATHOGENESIS, DIAGNOSIS, AND TREATMENTS -- CARDIOLOGY RESEARCH AND CLINICAL DEVELOPMENTS -- PULMONARY HYPERTENSIONPATHOGENESIS, DIAGNOSIS, AND TREATMENTS -- Library of Congress Cataloging-in-Publication Data -- Contents -- Preface -- Editor's Affiliation -- CHAPTER 1. Pulmonary Hypertension: Pathogenesis, Diagnosis, and Treatments -- Abstract -- Introduction -- Pathogenic Mechanisms -- Cellular Mechanisms -- Smooth Muscle Cells and Fibroblasts -- Endothelial Cells -- Inflammatory Cells -- Platelets and Thrombosis -- Molecular Mechanisms -- Genetic Association -- Acquired/Exogenous Factors -- Vascular Effectors -- Diagnosis -- Screening -- ECG -- Chest X-ray -- Chest CT -- Echocardiography -- Magnetic Resonance Imaging -- Treatments -- General Measures and Supportive Therapy -- Calcium-Channel Blockers -- Anticoagulation -- Prostacyclin Therapy -- Prostacyclin Analogs -- Nitric Oxide -- Phosphodiesterase Type 5 inhibitors -- Endothelin -Receptorantagonists -- Combination Therapy -- Management of PH associated with Congenital Systemic-to-pulmonary Shunts and Eisenmenger's Syndrome -- Novel Speculative Therapies -- Rho-kinase Inhibitor: Fasudil -- PDGF Receptor Antagonist: Imatinib -- Simvastatin -- Ghrelin -- Bradykinin -- Fluoxetine -- Potassium Channel Augmentation -- Apoptosis Signal-Regulating Kinase 1 -- Peroxisome Proliferator-Activated Receptor Gamma -- Elastase Inhibitors -- Survivin -- Conclusion -- References -- CHAPTER 2. Possible Bridging to Final Repair in Eisenmenger Syndrome -- Abstract -- Background -- Pathophysiology of Eisenmenger Syndrome (ES) -- Evaluation of Operability -- Attempts to Increase Operability of ES Patients -- Medical Attempt -- Surgical Attempt -- #ASD -- (1) Shunt Closure with Preceding Targeted Therapies -- (2) Fenestrated ASD Occluder -- #VSD. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | a. Pop-off Flap and Fenestrated Patch -- b. Pulmonary Artery Banding (PAB) -- #TGA/VSD -- a. Palliative Atrial Switch -- b. Arterial Switch -- Conclusion -- Reference -- CHAPTER 3. The Management of Congenital Systemic-to-Pulmonary Shunt and Advanced Pulmonary Artery Hypertension -- Abstract -- Background -- Methods and results -- Conclusion -- Abbreviations -- Patients and Methods -- Patients -- End Point -- Therapeutic Regimen -- Follow up -- Statistical Analysis -- Results -- The Results from the Whole Cohort of the 1212 Cases of Unmatched Patient -- The Results from the 245 Propensity-Matched Pairs -- The Results of Multivariate Logistic Regression and Cox Proportional Hazard Analysis for the Propensity-matched Patients -- Discussion -- Study Limitation -- References -- CHAPTER 4. Systemic Inflammatory Response Syndrome Associated with Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension -- Abstract -- Background -- Material and Methods -- Results -- Conclusion -- Abbreviations -- Introduction -- Material and Methods -- Surgical Procedure -- Anesthetic Management -- Hemodynamic Status -- Cytokines, PCT and acute-phase proteins analysis -- Statistical Analysis -- Results -- Conclusion -- Acknowledgment -- References -- CHAPTER 5. Liver Transplantation and Pulmonary Hypertension -- Abstract -- Introduction -- Portopulmonary Hypertension -- Pathophysiology -- Presentation -- Screening -- Pharmacotherapy -- Staging of POPH: Risk Management -- Perioperative Management -- Acute Decompensated Pulmonary Hypertension -- Postoperative Care -- Conclusion -- References -- CHAPTER 6. Pulmonary Hypertension in the Down Syndrome Population -- Abstract -- Introduction -- References -- Index. |
588 ## - SOURCE OF DESCRIPTION NOTE | |
Source of description note | Description based on publisher supplied metadata and other sources. |
590 ## - LOCAL NOTE (RLIN) | |
Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pulmonary hypertension. |
655 #4 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
Relationship information | Print version: |
Main entry heading | Gan, Huili |
Title | Pulmonary Hypertension: Pathogenesis, Diagnosis and Treatments |
Place, publisher, and date of publication | Hauppauge : Nova Science Publishers, Incorporated,c2012 |
International Standard Book Number | 9781614705567 |
797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
Uniform title | Cardiology Research and Clinical Developments |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3020361">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3020361</a> |
Public note | Click to View |
No items available.